Jill Muileboom1, Marsha Hamilton1, Karen Parent1, Donna Makahnouk1, Michael Kirlew2, Raphael Saginur3, Freda Lam4, Len Kelly2. 1. Sioux Lookout Meno Ya Win Health Centre, Sioux Lookout; 2. Division of Clinical Sciences, Northern Ontario School of Medicine, Sioux Lookout; 3. Division of Infectious Diseases, Ottawa Hospital Research Institute and Faculty of Medicine, University of Ottawa, Ottawa, Ontario; 4. Public Health Ontario.
Abstract
BACKGROUND: The incidence of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is traditionally high in remote areas of Canada with large Aboriginal populations. Northwestern Ontario is home to 28,000 First Nations people in more than 30 remote communities; rates of CA-MRSA are unknown. OBJECTIVE: To determine the CA-MRSA rates and antibiotic susceptibilities in this region. METHODS: A five-year review of laboratory and patient CA-MRSA data and antibiotic susceptibility was undertaken. RESULTS: In 2012, 56% of S aureus isolates were CA-MRSA strains, an increase from 31% in 2008 (P=0.06). Reinfection rates have been increasing faster than new cases and, currrently, 25% of infections are reinfections. CA-MRSA isolates continue to be susceptible to many common antibiotics (nearly 100%), particularly trimethoprim/sulfamethoxazole, clindamycin and tetracycline. Erythromycin susceptibility stands at 58%. DISCUSSION: Rates of CA-MRSA, as a percentage of all S aureus isolates, were higher than those reported in other primary care series. The infection rate per 100,000 is one the highest reported in Canada. Antibiotic susceptibilities were unchanged during the study period; the 99% susceptibility rate to clindamycin differs from a 2010 Vancouver (British Columbia) study that reported only a 79% susceptibility to this antibiotic. CONCLUSION: There are very high rates of CA-MRSA infections in northwestern Ontario. Disease surveillance and ongoing attention to antibiotic resistance is important in understanding the changing profile of MRSA infections. Social determinants of health, specifically improved housing and sanitation, remain important regional issues.
BACKGROUND: The incidence of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is traditionally high in remote areas of Canada with large Aboriginal populations. Northwestern Ontario is home to 28,000 First Nations people in more than 30 remote communities; rates of CA-MRSA are unknown. OBJECTIVE: To determine the CA-MRSA rates and antibiotic susceptibilities in this region. METHODS: A five-year review of laboratory and patient CA-MRSA data and antibiotic susceptibility was undertaken. RESULTS: In 2012, 56% of S aureus isolates were CA-MRSA strains, an increase from 31% in 2008 (P=0.06). Reinfection rates have been increasing faster than new cases and, currrently, 25% of infections are reinfections. CA-MRSA isolates continue to be susceptible to many common antibiotics (nearly 100%), particularly trimethoprim/sulfamethoxazole, clindamycin and tetracycline. Erythromycin susceptibility stands at 58%. DISCUSSION: Rates of CA-MRSA, as a percentage of all S aureus isolates, were higher than those reported in other primary care series. The infection rate per 100,000 is one the highest reported in Canada. Antibiotic susceptibilities were unchanged during the study period; the 99% susceptibility rate to clindamycin differs from a 2010 Vancouver (British Columbia) study that reported only a 79% susceptibility to this antibiotic. CONCLUSION: There are very high rates of CA-MRSA infections in northwestern Ontario. Disease surveillance and ongoing attention to antibiotic resistance is important in understanding the changing profile of MRSA infections. Social determinants of health, specifically improved housing and sanitation, remain important regional issues.
Authors: G R Golding; P N Levett; R R McDonald; J Irvine; M Nsungu; S Woods; A Horbal; C G Siemens; M Khan; M Ofner-Agostini; M R Mulvey Journal: Epidemiol Infect Date: 2010-01-22 Impact factor: 2.451
Authors: Marianna Ofner-Agostini; Andrew E Simor; Michael Mulvey; Elizabeth Bryce; Mark Loeb; Allison McGeer; Alex Kiss; Shirley Paton Journal: Infect Control Hosp Epidemiol Date: 2006-02-08 Impact factor: 3.254
Authors: Kathy K Byrd; Robert C Holman; Michael G Bruce; Thomas W Hennessy; Jay D Wenger; Dana L Bruden; Dana L Haberling; Claudia Steiner; James E Cheek Journal: Clin Infect Dis Date: 2009-10-01 Impact factor: 9.079
Authors: George R Golding; Paul N Levett; Ryan R McDonald; James Irvine; Brian Quinn; Mandiangu Nsungu; Shirley Woods; Mohammad Khan; Marianna Ofner-Agostini; Michael R Mulvey Journal: Emerg Infect Dis Date: 2011-04 Impact factor: 6.883
Authors: Eleonora Cella; Catherine G Sutcliffe; Carol Tso; Ella Paul; Nina Ritchie; Janene Colelay; Estar Denny; Lindsay R Grant; Robert C Weatherholtz; Laura L Hammitt; Taj Azarian Journal: Microb Genom Date: 2022-05